Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-23-001803

Interim President & CEO sold 6,766 shares at $15.00 ($101,490)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gould Robert J Interim President & CEO 2023-01-13 Sale −6,766 $15.00 $101,490 499,864 D
Open-market sales · 6,766 sh · avg $15.00 · $101,490
Loading xslF345X03/doc4.xml…